SEARCH RESULT

Total Matching Records found : 943

Medicines: For Saving Life or For Superprofits? by Bharat Dogra

Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...

More »

Even a CAT scan has a 4-month wait list at AIIMS by Kounteya Sinha

It could take you as long as two years to get a date for a simple MRI scan in the country's premier All India Institute of Medical Sciences (AIIMS) while a CAT scan has a waiting period of more than four months. Patients requiring a total hip replacement or a total knee replacement, will wait for no less than 5 months. A waiting list - ranging from 2 months to...

More »

Health in crisis by Mohan Rao

There are fears that curative health care will be left to the private sector, while the public system will handle preventive and low-quality care. AN issue of The Lancet earlier this year highlighted some of the problems with public health in India, acknowledging that “it is in crisis”. The robust economic growth over the past 20 years has not translated into better health indices; indeed the decline of infant and child...

More »

Affordable medicine

-The Business Standard   It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...

More »

Panel suggests price control in Essential Drug List by Kounteya Sinha

Drug prices have shot up phenomenally in India over the past decade and a half. A Planning Commission's expert group says there was nearly 40% rise in all drug prices between 1996 and 2006, thanks to the nation's pricedecontrol policies of the 1990s. Citing a study conducted in 2008, the Commission's high-level expert group (HLEG) on universal health coverage, headed by Dr K Srinath Reddy, says during the same period...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close